BioRegion Newsmakers

Premium

HCP Names Thomas Herzog as Executive Vice President/CFO as Mark Wallace Resigns

Thomas Herzog has been hired by publicly traded HCP as its executive vice president and chief financial officer effective May 1.

Herzog succeeds Mark Wallace, who held those positions as well as treasurer. Wallace will resign effective March 31, but "has agreed to serve in a consulting capacity until March 31, 2010, to assist in the transition" at the request of the board of directors, according to an HCP statement.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PNAS this week: epigenetic changes linked with high-altitude pulmonary edema, transcriptome profiling of maize leaf development, and more.

Stanford University researchers are studying top athletes to uncover genes linked to performance.

The UW's Wylie Burke and Dartmouth's Gilbert Welch argue that whole-genome testing may do more harm than good, and a related poll.

In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.